The Cannabis Industry is one of the most highly regulated industries in the world, on par with banking, financial services, pharmaceuticals, and health care with regard to the depth and complexity of the regulatory framework.
Not only are cannabis businesses subject to state licensing and regulatory requirements, they must also adhere to city, county, and federal (yes, federal) regulations and authorities as well. Operating a cannabis business is highly complex and the overall risk of doing so is significant and subject to many pitfalls.
Most people have no doubt seen or at least heard of purple weed or purple bud (not to be confused with Purple Haze). You may have even asked yourself how one goes about making purple weed?
Is purple weed better or stronger than regular green colored weed? Should I be paying more for purple weed? Firstly, to put a couple of those questions to bed. Purple weed has absolutely no difference in strength or potency at all. It is merely a physical characteristic of the plant. Thus no, you should not be paying more for purple buds unless you love the color so much you are willing to pay more for it.
Asthma is one of those hard to see conditions that affects millions of people on a daily basis. Often believed to be triggered by bacterial or viral infections in early childhood, it can be a life-long condition.
The effects on quality of life can take their toll, but hope is on the horizon, thanks to medical marijuana.
According to the World Health Organization, 1-in-12 people had asthma in the U.S. in 2009, up from 1-in-14 in 2001. 185 children and 3,262 adults died from asthma in 2007. On average, the condition cost the United States about $3,300 dollars per person with asthma each year from 2002 to 2007 in medical expenses, missed school and work days, and early deaths. The total costs rose from $53 billion to $56 billion in the same period.